Search by Drug Name or NDC
NDC 00143-9787-10 Enalaprilat 1.25 mg/mL Details
Enalaprilat 1.25 mg/mL
Enalaprilat is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is ENALAPRILAT DIHYDRATE.
Product Information
| NDC | 00143-9787 |
|---|---|
| Product ID | 0143-9787_bde8c35d-1cf2-42ea-a2a7-c4eb165e6d0d |
| Associated GPIs | 36100025102210 |
| GCN Sequence Number | 000383 |
| GCN Sequence Number Description | enalaprilat dihydrate VIAL 1.25 MG/ML INTRAVEN |
| HIC3 | A4D |
| HIC3 Description | ANTIHYPERTENSIVES, ACE INHIBITORS |
| GCN | 47580 |
| HICL Sequence Number | 013237 |
| HICL Sequence Number Description | ENALAPRILAT DIHYDRATE |
| Brand/Generic | Generic |
| Proprietary Name | Enalaprilat |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | enalaprilat |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 1.25 |
| Active Ingredient Units | mg/mL |
| Substance Name | ENALAPRILAT DIHYDRATE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Decreased Blood Pressure [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078687 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 00143-9787-10 (00143978710)
| NDC Package Code | 0143-9787-10 |
|---|---|
| Billing NDC | 00143978710 |
| Package | 10 VIAL in 1 CARTON (0143-9787-10) / 1 mL in 1 VIAL (0143-9787-01) |
| Marketing Start Date | 2008-12-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |